Beth Dawn Kaufman, MD
Pediatric Cardiology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location
Hospitals listed: Lucile Salter Packard Children'S Hsp at Stanford. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kaufman’s office at (650) 497-8000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence C55584 · Current
Licensed to practise in California · since 2012 · expires 2028-06-30 · Cornell University Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatric Cardiology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Lucile Salter Packard Children'S Hsp at StanfordPalo Alto, CAChildren · Voluntary non-profit - Private · No emergency departmentPart of Stanford Health Care, which runs 3 hospitalsNo overall ratingNo measure marked better or worse than the national rate
Medicaid work
$181 in 2023
Medicaid paid $181 for 12 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 12 | $181 |
| 2023 | 12 | 1 | 12 | $181 |
| 2021 | 39 | 2 | 15 | $1,613 |
| 2019 | 12 | 1 | 12 | $1,624 |
| 2018 | 169 | 2 | 18 | $15,424 |
See the largest Medicaid services in earlier years
2021
| Return visit (30+ min) | 15 | $1,338 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 24 | $276 |
2019
| Long return visit (40+ min) | 12 | $1,624 |
2018
| Long return visit (40+ min) | 121 | $12,613 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 48 | $2,811 |
Money from drug and device companies
$160 in 2024
| 2024 | 1 | 3 | None | $160 |
| 2023 | 1 | 1 | None | $18 |
| 2022 | 1 | 2 | None | $200 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Paragonix Technologies | None | $160 | 3 payments
|
See all 3 published payments
| Paragonix Technologies | Meals · 2024-04-11 | None | $143 |
| Paragonix Technologies | Meals · 2024-04-11 | None | $2 |
| Paragonix Technologies | Meals · 2024-04-11 | None | $15 |
See earlier years (2023, 2022)
2023: $18
| Nestle Healthcare Nutrition | Zenpep | $18 | 1 payment
|
2022: $200
| Intra-Sana Laboratories | Reltone 200 Mg | $200 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| E.R. Squibb & Sons, L.L.C. · A Randomized, Double-Blind, Placebo-Controlled Clinical Study To Evaluate Mavacamten in Adolescents (Age 12 Years To < 18 Years) With Symptomatic Obstructive Hypertrophic Cardiomyopathy · 2025 | Their institution | $72,782 |
| Novartis Pharmaceuticals Corporation · A Multicenter Study To Evaluate Safety and Tolerability of Open Label Lcz696 in Pediatric Heart Failure Patients Who Have Successfully Completed the Panorama Hf Study A · 2022 | Their institution | $39,498 |
| Novartis Pharmaceuticals Corporation · Multicenter Open Label Study To Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics Oflcz696 Followed By A 52 Week Randomized Double Blind Parallel Group Active Controlled Study To Evaluate the Efficacy and Safety of Lcz696 Compared With En · 2020 | Their institution | $36,670 |
| E.R. Squibb & Sons, L.L.C. · Mava Pediatrics Global Study · 2024 | Their institution | $19,352 |
| Novartis Pharmaceuticals Corporation · A Multicenter Study To Evaluate Safety and Tolerability of Open Label Lcz696 in Pediatric Heart Failure Patients Who Have Successfully Completed the Panorama Hf Study A · 2021 | Their institution | $14,336 |
| Novartis Pharmaceuticals Corporation · A Multicenter Study To Evaluate Safety and Tolerability of Open Label Lcz696 in Pediatric Heart Failure Patients Who Have Successfully Completed the Panorama Hf Study A · 2020 | Their institution | $12,711 |
| E.R. Squibb & Sons, L.L.C. · A Randomized, Double-Blind, Placebo-Controlled Clinical Study To Evaluate Mavacamten in Adolescents (Age 12 Years To < 18 Years) With Symptomatic Obstructive Hypertrophic Cardiomyopathy · 2024 | Their institution | $11,517 |
| Novartis Pharmaceuticals Corporation · A Multicenter Study To Evaluate Safety and Tolerability of Open Label Lcz696 in Pediatric Heart Failure Patients Who Have Successfully Completed the Panorama Hf Study A · 2023 | Their institution | $7,529 |
| Novartis Pharmaceuticals Corporation · Multicenter Open Label Study To Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics Oflcz696 Followed By A 52 Week Randomized Double Blind Parallel Group Active Controlled Study To Evaluate the Efficacy and Safety of Lcz696 Compared With En · 2019 | Their institution | $5,216 |
| Novartis Pharmaceuticals Corporation · Multicenter Open Label Study To Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics Oflcz696 Followed By A 52 Week Randomized Double Blind Parallel Group Active Controlled Study To Evaluate the Efficacy and Safety of Lcz696 Compared With Enalapril in Pediatric Patients From 1 Month To 18 Years of Age With Heart Failure Due To Systemic Left Ventricle Systolic Dysfunction · 2023 | Their institution | $2,794 |
| Novartis Pharmaceuticals Corporation · Multicenter Open Label Study To Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics Oflcz696 Followed By A 52 Week Randomized Double Blind Parallel Group Active Controlled Study To Evaluate the Efficacy and Safety of Lcz696 Compared With Enalapril in Pediatric Patients From 1 Month To 18 Years of Age With Heart Failure Due To Systemic Left Ventricle Systolic Dysfunction · 2021 | Their institution | $2,149 |
| Novartis Pharmaceuticals Corporation · A Multicenter Study To Evaluate Safety and Tolerability of Open Label Lcz696 in Pediatric Heart Failure Patients Who Have Successfully Completed the Panorama Hf Study A · 2019 | Their institution | $556 |
Professional record
- NPI
- 1750301073
- Licence
- CA C55584, PA MD424682California C55584: Current · expires 2028-06-30
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00C555840, NJ 0043541, PA 101097507
- Taxonomy
- Federal specialty code 2080P0202X (2080P0202X); Pediatrics (208000000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2006-07-20
- NPI last updated
- 2024-04-11
- NPI record certified
- 2024-04-11
This is when the NPI record was last certified, not a medical board exam.